Details of the Drug Pharmacogenomic Perturbation Atlas

General Information of Drug (ID: DMJ56MS)

• Drug Name: BUTYLATEDHYDROXYTOLUENE Drug Info
• Synonyms: 2,6-Di-tert-butyl-4-methylphenol; 128-37-0; Butylated hydroxytoluene; Butylhydroxytoluene; 2,6-Di-tert-butyl-p-cresol; 2,6-Di-t-butyl-4-methylphenol; Ionol; DBPC; Stavox; Dibunol; BHT; Ionol CP; Topanol; Impruvol; Vianol; Dalpac; Ionole; Deenax; Antioxidant KB; 3,5-Di-tert-butyl-4-hydroxytoluene; Sumilizer BHT; Antioxidant 4K; Topanol O; Topanol OC; Vanlube PC; Vanlube PCX; Sustane BHT; Tenamene 3; Antioxidant DBPC; Antioxidant 29; Antioxidant 30; Tenox BHT; Nonox TBC; Chemanox 11; Ionol 1; Agidol; Catalin CAO-3; Advastab 401; Ionol (antioxidan
• Cross-matching ID:
  PubChem CID: 31404
  ChEBI ID: CHEMBL146
  CAS Number: CAS 128-37-0
  TTD Drug ID: D0W1SL

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name	NES	FDR q-val	Tag %	Leading Edge Genes
Toxoplasmosis	-1.82	2.59e-2	103/112 (91.96%)	LAMA4;LAMA2;HLA-DOB;...
Citrate cycle (TCA cycle)	-1.95	0.00e+0	30/30 (100%)	IDH3A;FH;SDHA;...

Pharmacogenomic Perturbation Across Diseases and Tissues

Bone

Osteosarcoma

Cell Line Name	Cellosaurus Accession	Species of Origin	Drug Dosage	Time Point	Details
U-2 OS	CVCL_0042	Homo sapiens	10uM	6H	Hide ▲